Adar1 Capital Management, LLC Akero Therapeutics, Inc. Transaction History
Adar1 Capital Management, LLC
- $530 Billion
- Q2 2024
A detailed history of Adar1 Capital Management, LLC transactions in Akero Therapeutics, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 25,507 shares of AKRO stock, worth $783,064. This represents 0.11% of its overall portfolio holdings.
Number of Shares
25,507
Previous 1,807
1311.57%
Holding current value
$783,064
Previous $45.6 Million
1210.97%
% of portfolio
0.11%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding AKRO
# of Institutions
170Shares Held
72.7MCall Options Held
178KPut Options Held
164K-
Janus Henderson Group PLC London, X06.88MShares$211 Million0.09% of portfolio
-
Black Rock Inc. New York, NY5.59MShares$172 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.43MShares$167 Million2.13% of portfolio
-
General Atlantic LLC New York, NY5.23MShares$161 Million3.88% of portfolio
-
Wellington Management Group LLP Boston, MA5.11MShares$157 Million0.02% of portfolio
About Akero Therapeutics, Inc.
- Ticker AKRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,417,600
- Market Cap $1.43B
- Description
- Akero Therapeutics, Inc., a cardio-metabolic nonalcoholic steatohepatitis (NASH) company, engages in the development of medicines designed to restore metabolic balance and improve overall health. The company's lead product candidate is efruxifermin (EFX), an analog of fibroblast growth factor 21, which protects against cellular stress and regula...